Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost

PHASE2CompletedINTERVENTIONAL

Enrollment

138

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2008

Conditions

Open-angle GlaucomaOcular Hypertension

Interventions

DRUG

Travoprost ophthalmic solution, 0.0008%

DRUG

Travoprost ophthalmic solution, 0.001%

DRUG

Travoprost ophthalmic solution, 0.0012%

DRUG

TRAVATAN

OTHER

Vehicle

Trial Locations (1)

Contact Alcon Call Center at 1-888-451-3937, Fort Worth